成纤维细胞生长因子21对二乙基亚硝胺诱导的L02肝细胞癌变的抑制作用

李舒欢; 韩继武

doi:10.3969/j.issn.1001-5256.2018.02.020

成纤维细胞生长因子21对二乙基亚硝胺诱导的L02肝细胞癌变的抑制作用

DOI: 10.3969/j.issn.1001-5256.2018.02.020

哈尔滨医科大学附属第四医院消化内科

详细信息

中图分类号: R735.7
计量
- 文章访问数: 321
- HTML全文浏览量: 16
- PDF下载量: 116
- 被引次数: 0
出版历程
- 出版日期: 2018-02-20

Inhibitory effect of fibroblast growth factor-21 on the carcinogenesis of L02 cells induced by diethylnitrosamine

Department of Gastroenterology, The Fourth Affiliated Hospital of Harbin Medical University

摘要

摘要:
目的探讨成纤维细胞生长因子（FGF）21对二乙基亚硝胺（DEN）诱导的L02肝细胞癌变的抑制作用。方法培养L02肝细胞,分别用不同浓度的DEN（1、10、20、50、100和150μmol/L）作用,MTT法测定DEN对L02肝细胞活力的影响,选择适当的DEN刺激浓度（20μmol/L）进行后续实验。同时,分别采用丙二醛（MDA）及超氧化物歧化酶（SOD）检测试剂盒检测DEN（20μmol/L）作用细胞和正常L02细胞内的MDA及SOD水平。将L02肝细胞分为模型对照组（20μmol/L DEN+PBS处理）、FGF21低剂量组（20μmol/L DEN+1μmol/L FGF21蛋白）和FGF21高剂量组（20μmol/L DEN+2μmol/L FGF21蛋白）。细胞培养12 h后,检测细胞内的MDA及SOD水平。同时采用Real-time PCR和Western Blot检测β-Klotho（KLB）的表达水平,并用Western Blot检测蛋白激酶B（PKB,又称AKT）磷酸化水平。计量资料2组间比较采用t检验,多组间比较采用方差分析,进一步两两比较采用LSD-t检验。结果 ...
- 肝细胞 /
- 成纤维细胞生长因子 /
- 二乙基亚硝胺 /
- 氧化性应激
Abstract:
Objective To investigate the inhibitory effect of fibroblast growth factor-21 (FGF-21) on the carcinogenesis of L02 cells induced by diethylnitrosamine (DEN) .Methods L02 cells were cultured and treated with different concentrations of DEN (1, 10, 20, 50, 100, and 150 μmol/L) .MTT assay was used to measure the influence of DEN on the viability of L02 cells, and an appropriate stimulation concentration of DEN (20 μmol/L) was selected for further study.The malondialdehyde (MDA) and superoxide dismutase (SOD) detection kits were used to measure the levels of MDA and SOD in L02 cells treated by DEN (20μmol/L) and normal L02 cells.Then L02 cells were divided into model control group (treated with 20μmol/L DEN and PBS) , low-dose FGF-21 group (20 μmol/L DEN + 1 μmol/L FGF-21) , and high-dose FGF-21 group (20 μmol/L DEN + 2 μmol/L FGF-21) .The levels of MDA and SOD were measured after 12 hours of cell culture.Real-time PCR and Western blot were used to measure the expression of βKlotho (KLB) , and Western blot was used to measure the level of phosphorylated protein kinase B (p-AKT) .The t-test was used for comparison of continuous data between two groups; an analysis of variance was used for comparison between multiple groups, and the least significant difference t-test was used for further comparison between two groups.Results There was a significant increase in the level of MDA and a significant reduction in the level of SOD after L02 cells were treated with DEN (t = 9.336 and 16.281, P = 0.011 and 0.004) .Compared with the model control group, the low-and high-dose FGF-21 groups had a significant reduction in the level of MDA and a significant increase in the level of SOD (P <0.05) , and compared with the low-dose FGF-21 group, the high-dose FGF-21 group had a significantly lower level of MDA and a significantly higher level of SOD (P = 0.030 and 0.042) , and there was a significant difference between two groups.The high-and low-dose FGF-21 groups had significantly higher mRNA expression of KLB than the model control group (P < 0.001) , and the high-dose FGF-21 group had significantly higher mRNA expression of KLB than the low-dose FGF-21 group (P < 0.001) , and there was a significant difference between two groups; the protein expression of KLB showed the same trend.The model control group had a significantly higher level of p-AKT than the other two groups (P < 0.05) , and the high-dose FGF-21 group had a significantly lower level of p-AKT than the low-dose FGF-21 group (P < 0.05) .Conclusion DEN can increase oxidative stress in L02 cells.By upregulating the expression of KLB, FGF-21 can reduce the level of p-AKT, inhibit oxidative stress in L02 cells induced by DEN, and thus inhibit the development of hepatocellular carcinoma.
- hepatocytes /
- fabroblast growth factors /
- diethylnitrosamine /
- oxidative stress

HTML全文

参考文献(25)

[1]TURATI F, TALAMINI R, PELUCCHI C, et al.Metabolic syndrome and hepatocellular carcinoma risk[J].Br J Cancer, 2013, 108 (1) :222-228.

[2]CHEN W, ZHOU Y, GONG JP.Role of tumor-associated macrophages in development and progrssion of primary liver cancer[J].J Clin Hepatol, 2016, 32 (7) :1422-1424. (in Chinese) 陈伟, 周赟, 龚建平.肿瘤相关巨噬细胞在原发性肝癌发生发展中的作用[J].临床肝胆病杂志, 2016, 32 (7) :1422-1424.

[3]ZHANG DY, FRIEDMAN SL.Fibrosis-dependent mechanisms of hepatocarcinogenesis[J].Hepatology, 2012, 56 (2) :769-775.

[4]YAO RR, WANG YH.Progress in research on immune microenvironment in hepatocellular carcinoma[J].Chin J Clin Med, 2014, 21 (4) :487-496. (in Chinese) 姚蓉蓉, 王艳红.肝细胞肝癌免疫微环境的研究进展[J].中国临床医学, 2014, 21 (4) :487-496.

[5]DEGIlROLAMO C, SABBA C, MOSCHETTA A.Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23[J].Nat Rev Drug Dis, 2016, 15 (1) :51-69.

[6]GONG Q, ZHANG FF, HAN YM, et al.Metabolic actions of FGF21 and its clinical outcomes[J]Chin J Cell Bio, 2015, 37 (4) :460-468. (in Chinese) 龚琦, 张菲菲, 韩亚美, 等.FGF21的代谢调控及临床应用[J].中国细胞生物学学报, 2015, 37 (4) :460-468.

[7]YU Y, BAI F, LIU Y, et al.Fibroblast growth factor (FGF21) protects mouse liver against D-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways[J].Mol Cell Biochem, 2015, 403 (1-2) :287-299.

[8]NISHIMURA T, NAKATAKE Y, KONISHI M, et al.Identification of a novel FGF, FGF-21, preferentially expressed in the liver[J].Biochim Biophys Acta, 2000, 1492 (1) :203-206.

[9]LI DS, ZHANG YJ, XU PF, et al.Long-term administration of fibroblast growth factor 21 prevents DEN-induced hepatocarcinogenesis[J].J Northeast Agri Univ, 2016, 47 (3) :17-22, 30. (in Chinese) 李德山, 张瑛杰, 徐鹏飞, 等.长期注射成纤维细胞生长因子21对二乙基亚硝胺诱发肝癌的预防作用[J].东北农业大学学报, 2016, 47 (3) :17-22, 30.

[10]WU SD, MA YS, FANG Y, et al.Role of the microenvironment in hepatocellular carcinoma development and progression[J].Cancer Treat Rev, 2012, 38 (3) :218-225.

[11]TAHMASEBI BIRGANI M, CARLONI V.Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy[J].Int J Mol Sci, 2017, 18 (2) :405.

[12]NISHIDA N, KUDO M.Immunological microenvironment of hepatocellular carcinoma and its clinical implication[J].Oncology, 2017, 92 (Suppl 1) :40-49.

[13]WEN JY, ZHANG JR, ZHOU Y, et al.Effects of NADH on DENA-induced H-ras genemutation an dexpression of c-erb B-2 gene in L02 cells[J].Tumor, 2009, 29 (3) :210-214. (in Chinese) 温居一, 张积仁, 周媛, 等.NADH对DENA所致L02细胞Hras基因突变及c-erb B-2表达的影响[J].肿瘤, 2009, 29 (3) :210-214.

[14]WEN JY, ZHANG JR, LI P, et al.Effect of NADH on mutations of p53 gene and expression of c-er B 2 gene in L02 cells[J].Carcinog Teratogenesis Mutagen, 2009, 21 (5) :329-333. (in Chinese) 温居一, 张积仁, 李鹏, 等.NADH对二乙基亚硝胺所致L02人肝细胞株p53基因突变和c-erb B2基因表达的影响[J].癌变·畸变·突变, 2009, 21 (5) :329-333.

[15]LYU G, GAO L, GUO XL, et al.The role of p53 on the diethylnitrosamine-induced activation of activator protein 1 in hepatic cells[J].Med J Chin PLA, 2010, 35 (4) :398-401, 406. (in Chinese) 吕刚, 高璐, 郭献灵, 等.p53在二乙基亚硝胺诱导肝细胞转录因子AP-1活化中的作用[J].解放军医学杂志, 2010, 35 (4) :398-401, 406.

[16]FUTAKUCHI M, HIROSE M, OGISO T, et al.Establishment of an in vivo highly metastatic rat hepatocellular carcinoma model[J].Jpn J Cancer Res, 1999, 90 (11) :1196-1202.

[17]PAULA SANTOS N, COLACO A, GIL DA COSTA RM, et al.Ndiethylnitrosamine mouse hepatotoxicity:time-related effects on histology and oxidative stress[J].Exp Toxicol Pathol, 2014, 66 (9-10) :429-436.

[18]SHIMOMURA Y, TAKAKI A, WADA N, et al.The serum oxidative/anti-oxidative stress balance becomes dysregulated in patients with non-alcoholic steatohepatitis associated with hepatocellular carcinoma[J].Intern Med, 2017, 56 (3) :243-251.

[19]TSUKIYAMA-KOHARA K.Role of oxidative stress in hepatocarcinogenesis induced by hepatitis C virus[J].Int J Mol Sci, 2012, 13 (11) :15271-15278.

[20]ZHUANG YF, LI HL, YAO L, et al.Investigation of the mechanisms of mitochondrial dysfunction and antioxidative defense in hepatic tumor cells[J].Tumor, 2015, 35 (7) :713-722. (in Chinese) 庄云芳, 李慧玲, 姚亮, 等.肝肿瘤线粒体功能障碍及抗氧化应激机制的探讨[J].肿瘤, 2015, 35 (7) :713-722.

[21]YE D, WANG Y, LI H, et al.Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1alpha-mediated antioxidant capacity in mice[J].Hepatology, 2014, 60 (3) :977-989.

[22]SCHAAP FG, KREMER AE, LAMERS WH, et al.Fibroblast growth factor 21 is induced by endoplasmic reticulum stress[J].Biochimie, 2013, 95 (4) :692-699.

[23]LUO Y, YANG C, LU W, et al.Metabolic regulator beta Klotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation[J].J Biol Chem, 2010, 285 (39) :30069-30078.

[24]YE X, GUO Y, ZHANG Q, CHEN W, et al.b Klotho suppresses tumor growth in hepatocellular carcinoma by regulating Akt/GSK-3b/cyclin D1 signaling pathway[J].PLo S One, 2013, 8 (1) :e55615.

[25]GHOSH A, SIL PC.Protection of acetaminophen induced mitochondrial dysfunctions and hepatic necrosis via Akt-NF-kappa B pathway:role of a novel plant protein[J].Chem Biol Interact, 2009, 177 (2) :96-106.

施引文献

资源附件(0)

访问统计